Indore Pharma Summit: Mapping the future of India pharma
From AI and smart manufacturing to sustainability,quality culture,faster drug development,and CDMO opportunities,the summit…
Author
Future will belong to collaborative and implementation-focused ecosystems
As India’s pharma cold chain industry evolves to support biologics, vaccines and other temperature-sensitive therapies, the focus…
Resilience: The new mantra for R&D
Geopolitical fragmentation is accelerating the shift toward regional trials, localised manufacturing, and flexible drug…
AI: Revolutionising Pharma R&D
From one-size-fits-all to precision medicine: AI’s impact on pharma
Drug development has traditionally followed a…
FDD Conclave – Mumbai Connect: Reimagining formulation R&D
The inaugural edition of FDD Conclave - Mumbai Connect, a city-focused platform brought together FR&D leaders to discuss…
In 2026, India serves as the reliable ‘technical engine’ for global research
How would you describe the current and evolving clinical research landscape in India, and what key shifts are shaping its future?…
BMS is committed to pioneering AI-driven innovation in pharma commercialisation
AI is reshaping pharma commercialisation, transforming how companies engage healthcare professionals and deliver scientific…
Automation, digitalisation, and integrated workflows are redefining India’s life sciences landscape
Nandakumar Kalathil, Country General Manager – India, Agilent Technologies, shares insights into Agilent’s performance, strategic…
Rx-to-OTC is not a channel shift—it’s a complete business model shift
By 2030, what will truly differentiate winning OTC players in India from the rest?
By 2030, the biggest differentiator for…
Quality Trailblazer emphasises that leadership commitment is non-negotiable
What motivated you to write Quality Trailblazer, and how does it address the most pressing quality challenges faced by the Indian…